FAPI PET/CT
68Ga-FAPI≈ 15 min on the scannerAdvanced molecular study
In simple words
Rather than targeting the cancer cell itself, FAPI targets the supportive scaffolding that tumours build around themselves. That scaffolding is abundant in exactly the cancers FDG finds hardest — pancreas, stomach, liver, and thin sheets of disease lining the abdomen. Background uptake is very low, so tumours stand out with striking clarity.
Questions this scan answers
- Is there tumour where FDG PET was unclear or negative?
- Is the abdominal or peritoneal disease more extensive than CT suggests?
- Is this a scar from old treatment, or live tumour?
The Prismaa difference
FAPI is only offered where the physics and the reporting expertise are both in place. We run it on digital PET and report it against the standardised criteria used in the published FAPI literature.
Usually recommended for
- Breast cancer, including lobular carcinoma, which FDG under-reads
- Pancreatic, gastric, liver, bile duct and peritoneal cancers
- Head-and-neck and sarcoma cases where FDG is equivocal
- Brain tumours, where normal brain's own sugar uptake masks FDG
- Diabetics and anyone in whom sugar-based imaging is unreliable
How to prepare
- No fasting. No blood sugar restrictions — a real advantage for diabetic patients.
- Drink water normally.
- Carry all prior imaging, particularly any recent FDG PET/CT.
Book this scan, or ask us whether it is the right one
We are happy to discuss the request with your treating doctor before you commit to an appointment.